Fundraising FoxLIfT Biosciences
1 known investors
Find your way into LIfT Biosciences
Sign up to see every warm intro you have to LIfT Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the LIfT Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lift Biosciences develops Immunomodulatory Alpha Neutrophils (IMANs), off-the-shelf neutrophil-lineage cell therapies designed to kill tumor cells and restart anti-tumor immune responses in cancer patients. The company is preparing a first-in-human Phase 1 trial in patients with advanced cervical, head, and neck cancers.
Investors · 1
Frequently asked questions
- What does LIfT Biosciences do?
- Lift Biosciences develops Immunomodulatory Alpha Neutrophils (IMANs), off-the-shelf neutrophil-lineage cell therapies designed to kill tumor cells and restart anti-tumor immune responses in cancer patients. The company is preparing a first-in-human Phase 1 trial in patients with advanced cervical, head, and neck cancers.
- Who are LIfT Biosciences's investors?
- LIfT Biosciences's investors include Lifespan Vision Ventures.